Get the Stockscreener App
10.00
0.70%
-0.07
After Hours:
13.75
3.75
+37.50%
Mbx Biosciences Inc stock is traded at $10.00, with a volume of 1.25M.
It is down -0.70% in the last 24 hours and down -24.92% over the past month.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
See More
Previous Close:
$10.07
Open:
$10.15
24h Volume:
1.25M
Relative Volume:
2.98
Market Cap:
$335.94M
Revenue:
-
Net Income/Loss:
$-47.20M
P/E Ratio:
-6.3886
EPS:
-1.5653
Net Cash Flow:
$-43.65M
1W Performance:
-7.66%
1M Performance:
-24.92%
6M Performance:
+19.05%
1Y Performance:
-52.90%
1-Day Range:
$9.665
$10.28
1-Week Range:
$9.64
$11.19
52-Week Range:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Name
Mbx Biosciences Inc
Sector
Industry
Phone
(317) 989-3100
Address
11711 N. MERIDIAN STREET, CARMEL
Compare MBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
10.00 | 338.29M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Resumed | Jefferies | Buy |
| Aug-05-25 | Initiated | Mizuho | Outperform |
| Jul-16-25 | Initiated | Oppenheimer | Outperform |
| Apr-10-25 | Initiated | Citizens JMP | Mkt Outperform |
| Oct-08-24 | Initiated | Guggenheim | Buy |
| Oct-08-24 | Initiated | JP Morgan | Overweight |
| Oct-08-24 | Initiated | Jefferies | Buy |
| Oct-08-24 | Initiated | Stifel | Buy |
View All
Mbx Biosciences Inc Stock (MBX) Latest News
Pattern recognition hints at MBX Biosciences Inc. upside2025 Volatility Report & Consistent Growth Stock Picks - newser.com
Strategies to average down on MBX Biosciences Inc.July 2025 Momentum & Community Supported Trade Ideas - newser.com
MBX Biosciences to provide topline results from its phase 2 trial of Canvuparatide - MarketScreener
MBX Biosciences to Provide Topline Results from its Phase 2 - GlobeNewswire
Breakthrough Weekly HP Treatment Results Coming: MBX's Canvuparatide Phase 2 Data Release Monday - Stock Titan
Volume Summary: Is MBX Biosciences Inc stock forming a triangle patternJuly 2025 Volume & AI Powered Buy and Sell Recommendations - khodrobank.com
Bearish Setup: Can MBX Biosciences Inc. keep up with sector leadersJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - khodrobank.com
Institutional scanner results for MBX Biosciences Inc.Volume Spike & Daily Momentum Trading Reports - newser.com
Woodline Partners LP Acquires 268,740 Shares of MBX Biosciences, Inc. $MBX - MarketBeat
Top chart patterns to watch in MBX Biosciences Inc.Weekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Using R and stats models for MBX Biosciences Inc. forecastingEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
Using AI based signals to follow MBX Biosciences Inc.Weekly Trend Summary & AI Powered Market Trend Analysis - newser.com
How institutional ownership impacts MBX Biosciences Inc. stock2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Using RSI to spot recovery in MBX Biosciences Inc.July 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Inflation Data: What is MBX Biosciences Inc. s debt to equity ratio2025 Risk Factors & Verified Short-Term Trading Plans - خودرو بانک
Market Review: Is MBX Biosciences Inc. in a consolidation phaseProduct Launch & Safe Entry Momentum Tips - khodrobank.com
Entry Recap: Does MBX Biosciences Inc. meet Warren Buffett’s criteria2025 Major Catalysts & Weekly Top Gainers Trade List - khodrobank.com
Rate Hike: Is MBX Biosciences Inc. exposed to political riskMarket Activity Report & Safe Capital Growth Tips - khodrobank.com
Using data models to predict MBX Biosciences Inc. stock movement2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Real time breakdown of MBX Biosciences Inc. stock performanceMarket Trend Summary & Accurate Trade Setup Notifications - newser.com
Value Recap: Is MBX Biosciences Inc benefiting from interest rate changesEarnings Growth Report & Real-Time Volume Surge Alerts - khodrobank.com
Chipmakers Recap: Does MBX Biosciences Inc. meet Warren Buffett’s criteriaJuly 2025 Summary & Fast Exit/Entry Strategy Plans - khodrobank.com
MBX Biosciences (NYSE:MBX) versus Gemini Therapeutics (NASDAQ:GMTX) Financial Survey - Defense World
Trend Report: Is MBX Biosciences Inc part of any ETFJuly 2025 Update & Consistent Return Investment Signals - baoquankhu1.vn
Portfolio Update: Is MBX Biosciences Inc. exposed to political riskJuly 2025 Action & Growth Oriented Trade Recommendations - خودرو بانک
MBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street Zen - MarketBeat
Exome Asset Management LLC Makes New $982,000 Investment in MBX Biosciences, Inc. $MBX - MarketBeat
Analyzing net buyer seller activity in MBX Biosciences Inc.Market Performance Report & Stock Portfolio Risk Control - newser.com
Understanding MBX Biosciences Inc.’s price movement2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Is MBX Biosciences Inc. a candidate for recovery playQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Is this a good reentry point in MBX Biosciences Inc.July 2025 Momentum & Low Drawdown Momentum Ideas - Newser
Automated trading signals detected on MBX Biosciences Inc.Weekly Risk Summary & Proven Capital Preservation Tips - Newser
Mbx Biosciences Inc Stock (MBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):